×
For best experience we recommend to activate Javascript in your browser.
BRCA2 antibody (AA 2308-2537)
The Rabbit Polyclonal anti-BRCA2 antibody has been validated for WB, ELISA and IHC. It is suitable to detect BRCA2 in samples from Human.
Catalog No. ABIN7568319
$302.55
$355.94
save $53.39 (-15 %)
Plus shipping costs $50.00
Delivery in 12 to 14 Business Days
Quick Overview for BRCA2 antibody (AA 2308-2537) (ABIN7568319)
Target
See all BRCA2 Antibodies
BRCA2
(Breast Cancer 2, Early Onset (BRCA2))
Reactivity
All reactivities for BRCA2 antibodies
Human
Host
All hosts for BRCA2 antibodies
Rabbit
Clonality
All clonalities for BRCA2 antibodies
Polyclonal
Conjugate
All conjugates for BRCA2 antibodies
This BRCA2 antibody is un-conjugated
Application
All applications for BRCA2 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-BRCA2 Antibody
(hide)
Binding Specificity
All epitopes for BRCA2 antibodies
AA 2308-2537
Purpose
Anti-Human BRCA2 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human BRCA2 (Lys2308-His2537).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for BRCA2
(hide)
Target
BRCA2
(Breast Cancer 2, Early Onset (BRCA2))
Alternative Name
BRCA2
Background
BRCA2, FANCD1, FACD, Fanconi anemia group D1 protein, Breast cancer type 2 susceptibility protein
UniProt
P51587
Pathways
DNA Damage Repair , M Phase , Maintenance of Protein Location
Recently viewed
(hide)
Chat with us , powered by LiveChat